Goldman Sachs
GDRX icon

Goldman Sachs’s GoodRx Holdings GDRX Stock Holding History

Goldman Sachs’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-28,600
Closed -$1.17M – 6541
2021
Q3 		$1.17M Hold
28,600
– – ﹤0.01% 4619
2021
Q2 		$1.03M Buy
+28,600
New +$1.06M ﹤0.01% 4736

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Silver Lake Group
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs's GDRX Position: Q2 2026 in Review

Goldman Sachs reduced its GoodRx Holdings (GDRX) stake by 19% in Q2 2026, selling an estimated $507K and leaving 858,326 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #4510.

Goldman Sachs first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $101M in Q2 2021. 163 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Goldman Sachs held 858,326 shares of GoodRx Holdings worth $2.47M as of Q2 2026.
  • Goldman Sachs sold 199,635 GoodRx Holdings shares in Q2 2026, an estimated $507K.
  • GoodRx Holdings made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4510 holding.
  • Goldman Sachs first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
  • Goldman Sachs's GoodRx Holdings position peaked at $101M in Q2 2021.
  • 163 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.